(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 35.22%90.4M | -8.56%55.05M | 6.83%303.32M | 36.48%90.69M | 18.75%85.57M | -21.09%66.86M | -0.80%60.2M | 154.29%283.93M | 39.15%66.45M | 158.39%72.06M |
Net income from continuing operations | 74.07%53.87M | 25.48%37.62M | -3.72%156.07M | 14.28%45.47M | 57.48%49.68M | -36.08%30.95M | -29.23%29.98M | 253.73%162.11M | 42.48%39.79M | 20.83%31.55M |
Operating gains losses | -289.49%-1.73M | 391.61%5.84M | -122.66%-4.86M | 66.13%-1.87M | -575.06%-1.91M | -67.40%913K | -1,640.77%-2M | -167.66%-2.18M | 5.39%-5.52M | -94.54%401K |
Depreciation and amortization | 5.51%30.96M | 6.53%30.53M | 51.37%120.2M | 21.80%31.48M | 77.75%30.72M | 70.16%29.34M | 50.53%28.66M | 78.89%79.41M | 63.66%25.84M | 58.73%17.28M |
Remuneration paid in stock | 67.67%2.05M | 68.61%2.72M | 28.27%5.24M | -16.01%902K | 64.07%1.5M | -12.44%1.23M | 131.04%1.62M | 49.85%4.09M | 8.70%1.07M | 50.16%913K |
Deferred tax | 77.36%16.64M | 25.86%11.56M | -5.37%46.9M | 13.40%13.41M | 55.54%14.93M | -37.29%9.38M | -30.33%9.19M | 878.79%49.57M | 133.49%11.82M | --9.6M |
Other non cashItems | 18.08%627K | 37.76%405K | 49.87%1.7M | 340.00%264K | -13.50%615K | 365.79%531K | -30.33%294K | -96.55%1.14M | -102.30%-110K | -75.21%711K |
Change In working capital | -57.63%-1.79M | -155.00%-4.63M | 169.15%7.05M | 183.45%5.39M | -148.39%-5.62M | -466.50%-1.13M | 155.54%8.41M | -62.86%-10.2M | -560.02%-6.46M | 419.31%11.61M |
-Change in receivables | -790.14%-5.69M | -228.91%-7.36M | 72.37%-3.5M | 163.29%5.01M | -193.96%-13.57M | -242.95%-639K | 129.05%5.71M | 49.61%-12.66M | 5.39%-7.91M | 318.96%14.45M |
-Change in inventory | 263.89%177K | -129.52%-209K | 177.91%455K | 234.31%184K | -203.79%-329K | -107.70%-108K | 132.67%708K | -237.57%-584K | 54.64%-137K | 368.64%317K |
-Change in prepaid assets | -1,759.09%-365K | -61.19%-432K | 7.14%-468K | 15.00%-306K | -75.07%84K | 107.05%22K | -58.58%-268K | -1,129.27%-504K | -222.03%-360K | 351.49%337K |
-Change in payables and accrued expense | 1,102.45%4.09M | 48.65%3.37M | 197.10%10.56M | -74.22%503K | 335.02%8.2M | 76.52%-408K | -66.81%2.27M | -81.37%3.56M | -73.60%1.95M | -208.59%-3.49M |
Tax refund paid | -135.21%-10.23M | -81.93%-29M | ---28.99M | ---4.35M | ---4.35M | ---4.35M | ---15.94M | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 35.22%90.4M | -8.56%55.05M | 6.83%303.32M | 36.48%90.69M | 18.75%85.57M | -21.09%66.86M | -0.80%60.2M | 154.29%283.93M | 39.15%66.45M | 158.39%72.06M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 4.07%-66.2M | 11.00%-51.58M | -5.02%-243.71M | 11.69%-54.72M | -14.74%-62.03M | -93.51%-69.01M | 27.89%-57.96M | -112.65%-232.06M | -31.69%-61.96M | -127.72%-54.06M |
Capital expenditure reported | 20.87%-50.72M | 6.08%-65.27M | 3.56%-240.07M | 41.97%-36.27M | 1.12%-70.21M | -91.61%-64.09M | 15.21%-69.49M | -77.31%-248.92M | -27.47%-62.51M | -90.39%-71M |
Net PPE purchase and sale | ---- | ---- | --3.75M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net other investing changes | -214.97%-15.49M | 18.64%13.69M | -143.84%-7.39M | -4,084.20%-22.19M | -51.72%8.18M | -122.29%-4.92M | 628.81%11.54M | -46.05%16.87M | -72.09%557K | 24.99%16.94M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 4.07%-66.2M | 11.00%-51.58M | -5.02%-243.71M | 11.69%-54.72M | -14.74%-62.03M | -93.51%-69.01M | 27.89%-57.96M | -112.65%-232.06M | -31.69%-61.96M | -127.72%-54.06M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 5.10%-22.53M | -0.39%-22.94M | -1,102.78%-89M | -635.33%-18.92M | -612.12%-23.49M | -2,552.07%-23.74M | -10,526.05%-22.85M | -74.93%8.88M | -88.16%3.54M | 7,298.39%4.59M |
Net issuance payments of debt | 448.73%687K | 448.73%687K | 28.43%-657K | 98.26%-88K | -103.82%-175K | 14.35%-197K | 15.09%-197K | -170.00%-918K | -2,975.00%-5.04M | 4,510.58%4.59M |
Cash dividends paid | -0.81%-23.73M | -1.14%-23.66M | ---94.16M | ---23.64M | ---23.59M | ---23.54M | ---23.39M | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | --516K | -95.29%35K | -45.04%1.01M | --0 | --270K | --0 | 4,270.59%743K | 10,138.89%1.84M | 111.03%628K | --0 |
Net other financing activities | ---- | ---- | -39.60%4.8M | ---- | ---- | ---- | ---- | -77.75%7.95M | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 5.10%-22.53M | -0.39%-22.94M | -1,102.78%-89M | -635.33%-18.92M | -612.12%-23.49M | -2,552.07%-23.74M | -10,526.05%-22.85M | -74.93%8.88M | -88.16%3.54M | 7,298.39%4.59M |
Net cash flow | ||||||||||
Beginning cash position | -18.25%126.58M | -16.75%146.05M | 52.96%175.45M | -22.95%129M | -10.96%128.96M | 63.33%154.85M | 52.96%175.45M | 49.41%114.7M | 99.00%167.42M | 81.22%144.84M |
Current changes in cash | 106.46%1.67M | 5.50%-19.47M | -148.39%-29.4M | 112.43%17.05M | -99.79%47K | -151.75%-25.89M | -3.53%-20.6M | 60.14%60.74M | -73.75%8.03M | 436.59%22.59M |
End cash Position | -0.54%128.26M | -18.25%126.58M | -16.75%146.05M | -16.75%146.05M | -22.95%129M | -10.96%128.96M | 63.33%154.85M | 52.96%175.45M | 52.96%175.45M | 99.00%167.42M |
Free cash from | 1,336.30%39.69M | -9.98%-10.22M | 80.69%63.25M | 1,283.22%54.42M | 1,350.42%15.36M | -94.61%2.76M | 56.31%-9.29M | 221.82%35M | 404.96%3.93M | 111.26%1.06M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data